Browse diseases

…/− macrophages is a promising therapeutic strategy for reducing HCC tumour growth.…

…d increased satisfaction.Conclusion Implementation of a digital liver cirrhosis tracker has improved surveillance delivery, patient engagement,…

…n shown to be protective against development and progression of hepatocellular carcinoma (HCC). We investigated in human in vitro models of pre-cancerou…

… surveillance for patients with cirrhosis to detect early-stage hepatocellular carcinoma (HCC). 1 The Ultrasound Liver Imaging Reporting and Data System…

…hibition of lactylation restores ICIs sensitivity in orthotopic HCC mouse models.Conclusions Our findings demonstrate that histone …

… (ICI) therapy in patients with anti-PD-1-refractory metastatic melanoma were reported in 2021 and demonstrated reinstatement of respons…

…Background Primary liver cancer, predominantly hepatocellular carcinoma (HCC), has limited ther…

…nd Recurrence after curative-intent resection remains common in hepatocellular carcinoma (HCC), and whether postoperative incretin-based treatment choic…

…d While the 5-year recurrence rate in patients with early-stage hepatocellular carcinoma (HCC) is around 50-70%, conventional prediction models have mai…

…ctive anti-HCV treatment and the disuse of protease inhibitors, HIV infection was no more associated to higher risk of rejection. H…

…ackground Immune checkpoint inhibitors (ICIs) enable successful hepatocellular carcinoma (HCC) downstaging or bridging for liver transplantation (LT) bu…

…Background Tumor-associated macrophages are pivotal drivers of hepatocellular carcinoma (HCC) progression. However, the functional contributions of pro…